SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.273
AS - Asia 11.700
EU - Europa 6.814
SA - Sud America 1.783
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 268
OC - Oceania 23
Totale 43.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.718
SG - Singapore 4.239
CN - Cina 3.026
DE - Germania 1.350
BR - Brasile 1.345
IT - Italia 1.300
VN - Vietnam 1.277
UA - Ucraina 1.014
HK - Hong Kong 950
TR - Turchia 758
GB - Regno Unito 653
FI - Finlandia 512
FR - Francia 447
SE - Svezia 412
RU - Federazione Russa 351
BD - Bangladesh 307
CA - Canada 295
JP - Giappone 286
PL - Polonia 274
IN - India 239
MX - Messico 165
AR - Argentina 158
NL - Olanda 130
ID - Indonesia 112
IQ - Iraq 98
ZA - Sudafrica 93
ES - Italia 85
CO - Colombia 62
EC - Ecuador 58
PK - Pakistan 56
LT - Lituania 51
BE - Belgio 49
VE - Venezuela 49
MA - Marocco 43
MY - Malesia 40
SA - Arabia Saudita 40
CL - Cile 39
UZ - Uzbekistan 34
AE - Emirati Arabi Uniti 32
PH - Filippine 28
PY - Paraguay 26
KE - Kenya 25
AT - Austria 24
CZ - Repubblica Ceca 24
TN - Tunisia 24
EG - Egitto 22
AU - Australia 19
IL - Israele 19
NP - Nepal 19
DZ - Algeria 18
JM - Giamaica 18
JO - Giordania 17
KR - Corea 17
IE - Irlanda 15
HN - Honduras 14
PE - Perù 14
UY - Uruguay 14
BO - Bolivia 13
CR - Costa Rica 13
AL - Albania 11
PT - Portogallo 11
TW - Taiwan 11
CH - Svizzera 10
RO - Romania 10
GR - Grecia 9
OM - Oman 9
TH - Thailandia 9
GT - Guatemala 8
IR - Iran 8
NI - Nicaragua 8
RS - Serbia 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
BG - Bulgaria 7
ET - Etiopia 7
HU - Ungheria 7
KG - Kirghizistan 7
SN - Senegal 7
EU - Europa 6
HR - Croazia 6
SV - El Salvador 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
KZ - Kazakistan 5
LB - Libano 5
LV - Lettonia 5
MD - Moldavia 5
NG - Nigeria 5
NO - Norvegia 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
MN - Mongolia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
Totale 42.797
Salva come PNG Salva come JPEG
Città #
Singapore 2.763
Ashburn 2.287
Woodbridge 1.756
San Jose 1.655
Fairfield 1.556
Jacksonville 1.097
Chandler 1.077
Houston 1.063
Beijing 947
Santa Clara 932
Hong Kong 930
Ann Arbor 878
Seattle 666
Council Bluffs 663
Wilmington 643
Cambridge 533
Dallas 450
Ho Chi Minh City 440
Los Angeles 423
Izmir 366
Nanjing 336
Ferrara 322
Hanoi 313
New York 298
Tokyo 269
Princeton 256
Warsaw 245
Milan 243
Munich 220
Lauterbourg 219
Helsinki 217
Boardman 203
Shanghai 149
São Paulo 147
Dearborn 126
San Diego 117
Orem 114
Shenyang 111
Nanchang 105
London 101
Buffalo 98
Addison 90
Hefei 90
Montreal 89
Mexico City 88
Tianjin 88
Falkenstein 85
Bremen 82
Toronto 82
Chicago 81
Turku 80
Frankfurt am Main 76
Jakarta 73
Brooklyn 72
Changsha 68
Atlanta 65
Hebei 64
Phoenix 64
Da Nang 62
San Francisco 62
Chennai 60
Denver 58
Bologna 57
Haiphong 54
Jinan 49
Johannesburg 48
Manchester 48
Brussels 47
Jiaxing 46
Rome 46
Stockholm 44
Boston 43
Moscow 43
San Mateo 43
Poplar 42
Amsterdam 40
The Dalles 40
Baghdad 39
Falls Church 39
Rio de Janeiro 39
Kunming 36
Philadelphia 36
Zhengzhou 36
Mountain View 35
Norwalk 33
Mumbai 32
Guangzhou 31
Tashkent 31
Columbus 29
Biên Hòa 27
Auburn Hills 26
Brasília 26
Charlotte 26
Ningbo 26
Ankara 25
Redwood City 25
Belo Horizonte 23
Hải Dương 23
Medellín 23
Verona 22
Totale 28.291
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 423
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 357
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 345
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 331
Caffeine alters A(2A) adenosine receptors and their function in human platelets 331
A glance at adenosine receptors: Novel target for antitumor therapy 321
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 300
The A3 adenosine receptor: history and perspectives 294
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 293
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 280
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 273
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 269
Adenosine receptors and human melanoma 264
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 263
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 262
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 262
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 260
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 252
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 250
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 249
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 247
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 241
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 241
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 237
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 237
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 236
Adenosine receptors and cancer 233
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 231
Adenosine receptor targeting in health and disease 230
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 225
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 225
van't Hoff Based Thermodynamics 225
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 224
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 223
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 223
Targeting A3 and A2A adenosine receptors in the fight against cancer 222
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 220
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 219
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 219
Pathological overproduction: the bad side of adenosine 219
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 218
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 218
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 217
Agonists and antagonists: Molecular mechanisms and therapeutic applications 217
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 216
Adenosine receptors in health and disease 214
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 213
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 212
Adenosine and lymphocyte regulation 212
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 211
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 211
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 209
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 209
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 207
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 207
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 206
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 206
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 206
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 205
A(2A) adenosine receptors in human peripheral blood cells 205
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 204
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 204
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 204
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 202
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 202
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 201
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 201
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 200
Adenosine in a human model of Hypoxic foam cells 200
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 200
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 199
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 198
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 197
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 197
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 194
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 194
New potent and selective human adenosine A3 receptor antagonists. 191
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 190
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 190
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 189
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 188
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 188
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 188
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 187
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 186
New potent and selective human adenosine A3 receptor antagonists 186
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 185
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 184
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 184
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 184
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 184
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 184
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 183
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 183
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 183
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 182
The A3 adenosine receptor: An enigmatic player in cell biology 181
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 181
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 181
Totale 22.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.383
Totale 191.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.884 0 0 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/202616.100 1.635 571 1.351 1.978 2.329 1.110 1.903 797 1.611 1.788 637 390
2026/20272.049 648 1.006 395 0 0 0 0 0 0 0 0 0
Totale 43.204